Vimarsana
Biggest News Aggregation in the World

Page 22 - Docket Number News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Docket Number. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Docket Number Today - Breaking & Trending Today

Assessing User Fees Under the Biosimilar User Fee Amendments of 2017 - Vimarsana News

Assessing User Fees Under the Biosimilar User Fee Amendments of 2017

User Fees

Source: fda.gov
Hydrogen Peroxide-Based Contact Lens Care Products: Consumer Labeling Recommendations - Premarket Notification (510(k)) Submissions - Vimarsana News

Hydrogen Peroxide-Based Contact Lens Care Products: Consumer Labeling Recommendations - Premarket Notification (510(k)) Submissions

This guidance provides labeling recommendations for hydrogen peroxide-based contact lens care products submitted in premarket notification (510(k)) submissions.

Source: fda.gov
CDER's Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality - Vimarsana News

CDER's Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality

CDER’s Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality

Source: fda.gov
Guidance for Industry | M7(R2) Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals To Limit Potential Carcinogenic Risk - Vimarsana News

Guidance for Industry | M7(R2) Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals To Limit Potential Carcinogenic Risk

M7(R2) Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals To Limit Potential Carcinogenic Risk

Source: fda.gov
M7(R2) ADDENDUM: APPLICATION OF THE PRINCIPLES OF THE ICH M7 GUIDELINE - Vimarsana News

M7(R2) ADDENDUM: APPLICATION OF THE PRINCIPLES OF THE ICH M7 GUIDELINE

Addendum to M7(R2)

Source: fda.gov